Evidence map›Paper›PMID 39408976›Full record

ArticleInternational journal of molecular sciences2024

The Immune Modulation

Fabio Suarez-Trujillo, Ignacio Juarez, Christian Vaquero-Yuste, Alberto Gutierrez-Calvo, Adela Lopez-García, Inmaculada Lasa, Remedios Gomez, José Manuel Martin-Villa, Antonio Arnaiz-Villena

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fabio Suarez-TrujilloDepartment of Immunology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Ignacio JuarezDepartment of Immunology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Christian Vaquero-YusteDepartment of Immunology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Alberto Gutierrez-CalvoDigestive and General Surgery Service, Principe de Asturias University Hospital, 28015 Madrid, Spain.
Adela Lopez-GarcíaDigestive and General Surgery Service, Principe de Asturias University Hospital, 28015 Madrid, Spain.
Inmaculada LasaDigestive and General Surgery Service, Principe de Asturias University Hospital, 28015 Madrid, Spain.
Remedios GomezDigestive and General Surgery Service, Principe de Asturias University Hospital, 28015 Madrid, Spain.
José Manuel Martin-VillaDepartment of Immunology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Antonio Arnaiz-VillenaDepartment of Immunology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human Leukocyte Antigen (HLA) system contains a set of genes involved at many levels in the innate and adaptive immune response. Among the non-classical HLA class I genes, HLA-G stands out for the numerous studies about its pivotal role in regulating/modulating immune responses. Also, its involvement in extravillous cytotrophoblast function, viral infections, autoimmunity, and cancer has been extensively documented. The present study explores for the first time the relationship between natural alleles of HLA-G, rather than STSs, SNPs, or partial gene polymorphisms, and the development of gastric adenocarcinoma, by analyzing the genetic profile of a cohort of 40 Spanish patients with this type of tumor using DNA extracted from paired biopsies of tumoral and adjacent non-tumoral gastric tissue. Our results reveal a significant statistical relationship between the presence of the

Indexed as

AdenocarcinomaAllelesHLA-G AntigensStomach NeoplasmsAdultAgedFemaleGene FrequencyGenetic Predisposition to DiseaseHaplotypesHumansMaleMiddle AgedPolymorphism, Single NucleotideHLA-G Antigenscancercomplotypesgastric adenocarcinomahaplotypesHLAHLA-GHLA-G*01:01:01immune modulationnon-classical HLAtolerance

Identifiers

PMID39408976
PMCPMC11476450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.